A new acorane sesquiterpene glucoside, 1R,3S,4R,5R,10R-3,10-dihydroxyacoronene-3-O-β-D-glucoside (1), was isolated from the EtOAc-soluble partition of the ethanol extract of Lysionotus pauciflorus, together with six known compounds, namely p-hydroxybenzoic acid (2), vanillic acid (3), caffeic acid (4), -hydroxypropiosyringone (5), α,-dihydroxypropiosyringone (6), and lyoniresinol (7). The structure of the new compound was elucidated on the basis of spectroscopic methods, including 1D and 2D NMR, and high-resolution MS analysis. The absolute configuration of 1 was determined from CD spectra. When evaluated against several bacterial and fungal strains, and human cancer cell lines, compound 1 and its aglycone were inactive.
Compound 1, amorphous colorless solid, C 21 H 34 O 8 [negative HR-ESI-MS, [M-H]ion peak at m/z 413.2176 (calcd. for 413.2175)], showed 21 signals (Table 1) in the 13 C NMR spectrum. Carbon signals at δ C 62. 7, 71.7, 75.1, 77.9, 78.0 and 102.5 suggested the presence of one molecule of β-D-glucose (anomeric proton at δ H 4.32, 1H, d, J = 7.6 Hz; anomeric carbon at δ C 102.5). The 1 H and 13 C NMR data of 1 suggested the existence of a trisubstituted olefin conjugated to a carbonyl group [ δ H 6.63 (1H, s), 1.73 (3H, t, J = 1.6 Hz); δ C 135. 7, 151.8, 201.8] , two oxygenated methine [δ H 4.73 (1H, t, J = 1.6 Hz), δ C 71.5; δ H 3.83 (1H, m), δ C 85.5], and the characteristic signals of an isopropyl group at δ H 0.98 (3H, d, J = 6.8 Hz), 1.03 (3H, d, J = 6.4 Hz). Analysis of the HSQC spectrum allowed the attachments of 14-Me to C-4 and 15-Me to C-8, which were further confirmed by the HMBC correlations from 14-Me [δ H 0.92 (3H, d, J = 7.2 Hz)] to C-3, C-4, and C-5, and 15-Me [δ H 1.73 (3H, t, J = 1.6 Hz)] to C-7, C-8, and C-9, respectively. In addition, the 1 H and 13 C NMR spectra also indicated the presence of a spiro carbon at δ C 53.5 of an acorane-type sesquiterpene. Further analysis showed that the data of 1 were similar to the known compound 3,10-dihydroxyacoronene (8), which was isolated from the same species in our previous work [3c]. The HMBC correlations from H-2 (δ H 1.66, 2.08), H-4 (δ H 2.38), and H-14 (δ H 0.92) to C-3(δ C 85.5), indicated that a hydroxyl group unit was attached to C-3. The 10-hydroxyl group was unambiguously assigned by the HMBC experiment, which showed the correlations of H-10 (δ H 4.73) with C-8 (δ C 135.7) and C-9 (δ C 151.8). The HMBC spectrum was also used to determine the site of attachment of the sugar and the aglycone. The signal of H-1 (δ H 4.32) of glucose was correlated to the signal of C-3 of the aglycone in the HMBC spectrum, which suggested that the glucose was bonded with the 3-OH of the aglycone. The absolute configuration of 1 was determined by CD [4] , and a small positive Cotton effect at 335.5 nm ( ε =+1.01), which was based on the n→π * transition of an α,unsaturated ketone [5] . From all the above data, the absolute configuration of compound 1 was concluded to be 1R, 3S, 4R, 5R, 10R. Therefore, based on the above evidence, the structure of 1 could be elucidated unambiguously as 1R,3S,4R,5R,10R-3,10dihydroxyacoronene-3-O-β-D-glucoside.
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Considering the plant's traditional uses in cancer treatment and biological activities, the antibacterial, antifungal and cytotoxic activities of compound 1 and its aglycone (8) were evaluated. An agar diffusion assay towards Escherichia coli, Bacillus subtilis, Staphylococcus aureus, Aspergillus fumigatus, and yeast were performed. However, neither compound showed any inhibition activities against the tested bacterial and fungal strains. In addition, cytotoxic activities against human breast adenocarcinoma (MCF-7), human hepatocelluar carcinoma (Hep-G2), human colon carcinoma (HCT-116), and human lung cancer (A549) cell lines by the MTT method were determined. Neither compound exhibited cytotoxicity against any of the four cell lines.
Six known compounds were identified by comparison with the literatures as p-hydroxybenzoic acid (2) [6a] , vanillic acid (3) [6b], caffeic acid (4) [6c], -hydroxypropiosyringone (5) [6d], α,dihydroxypropiosyringone (6) [6d], and lyoniresinol (7) [6e]. Interestingly, compounds 2, 5, 6, and 7 were isolated from this family for the first time.
Experimental
General: NMR, Bruker AM-400 spectrometer; HR-ESI-MS, Q-TOF premier spectrometer; CD, Jasco J-1500 CD spectrometer; Optical rotation, WZZ-3 polarimeter.
Plant material:
The whole plants of L. pauciflorus were purchased from a local herbal medicine store in Chengdu, Sichuan Province, China, in May 2010. The plant was identified by comparison with voucher specimens already deposited at the Herbarium of the Institute of Botany, Chinese Academy of Sciences, Kunming (No: KUN. 75167, collected on June 4, 1988) . A voucher specimen (D201002) was deposited at the Department of Pharmaceutics & Bioengineering, Sichuan University, Chengdu, China.
Extraction and isolation:
The air-dried and pulverized whole plants (5.0 kg) of L. pauciflorus were extracted with 95% ethanol (25 L×4) at room temperature, for 3 days each, and the combined extracts were concentrated in vacuum. The residue was suspended in distilled water, and fractionated into petroleum ether (PE), EtOAc, and n-BuOH soluble fractions. The EtOAc (44 g) soluble fraction was subjected to silica gel CC with a step gradient of PE-acetone (100:1 to 1:5), to yield 10 portions (A~J). Portion E was first applied to MCI resin CC with acetone-water mixture of decreasing polarity, followed by Sephadex LH-20 CC (MeOH) and preparative TLC (CH 2 Cl 2 :MeOH, 15:1) to yield compounds 2 (37 mg) and 3 (32.3 mg). Portion G was sectioned into 7 fractions (G1-G7) by MCI resin CC (acetone: H 2 O, 3:7 to 1:0). Fraction G1 was repeatedly chromatographed by MCI resin CC to obtain 5 subfractions G1a-G1e. Sub-fraction G1a was eluted by Sephadex LH-20 CC (MeOH) and further purified by PTLC (CH 2 Cl 2 : MeOH, 5:1) to obtain 5 (14.4 mg) and 6 (24.3 mg). Fraction G2 was separated by CC over Sephadex LH-20 eluted by MeOH to obtain 5 subfractions G2a-G2e. Separation of G2a and G2b by means of PTLC using CH 2 Cl 2 :MeOH (5:1) as the mobile phase gave pure 1 (21.3 mg) and 7 (10.5 mg), respectively. G2c was subjected to MCI resin CC (acetone: H 2 O, 3:7 to 7:3), followed by PTLC (CH 2 Cl 2 : MeOH, 5:1) to yield 4 (17.5 mg). 3S,4R,5R,10R-3,10-dihydroxyacoronene-3-O- Antimicrobial assay: Compounds were dissolved in DMSO at a concentration of 1 mg/mL. Forty μL of the solutions were added to 4 mm holes (inner diameter). Penicillin and nystatin were used as the positive controls for bacteria and fungi, respectively. The antimicrobial activity was evaluated by measuring the diameter of the inhibition zone formed on the agar.
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Cytotoxicity assay:
The cytotoxicity of compound 1 and its aglycone were evaluated by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] method. Cells in 100 μL medium were seeded in 96-well plates at a density of 2.0×10 3 cells/well. After incubation for 24 h at 37°C in a humidified 5% CO 2 atmosphere, test samples dissolved in DMSO at various concentrations were added and the plates were incubated for an additional 72 h. Then the cells were incubated with 5 mg/mL MTT at 37°C for 4 h; finally, the medium was discarded and DMSO was added to each well for 20 mins. The absorbance was measured at 570 nm with a Spectra MAXM5 microplate spectrophotometer and the percentage of inhibition was calculated.
